Glenthøj A - Search Results

1

Mitapivat versus Placebo for Pyruvate Kinase Deficiency.

Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ; ACTIVATE Investigators. Al-Samkari H, et al. Among authors: glenthoj a. N Engl J Med. 2022 Apr 14;386(15):1432-1442. doi: 10.1056/NEJMoa2116634. N Engl J Med. 2022. PMID: 35417638 Clinical Trial.

2

[No title available]

[No authors listed] [No authors listed] PMID: 32165483

3

A remarkable case of HbH disease illustrates the relative contributions of the α-globin enhancers to gene expression.

Badat M, Davies JOJ, Fisher CA, Downes DJ, Rose A, Glenthøj AB, van Beers EJ, Harteveld CL, Higgs DR. Badat M, et al. Among authors: glenthoj ab. Blood. 2021 Jan 28;137(4):572-575. doi: 10.1182/blood.2020006680. Blood. 2021. PMID: 33113553 Free article. No abstract available.

4

Serglycin participates in retention of α-defensin in granules during myelopoiesis.

Glenthøj A, Cowland JB, Heegaard NH, Larsen MT, Borregaard N. Glenthøj A, et al. Blood. 2011 Oct 20;118(16):4440-8. doi: 10.1182/blood-2011-06-362947. Epub 2011 Aug 17. Blood. 2011. PMID: 21849484 Free article.

5

miRNA-130a regulates C/EBP-ε expression during granulopoiesis.

Larsen MT, Häger M, Glenthøj A, Asmar F, Clemmensen SN, Mora-Jensen H, Borregaard N, Cowland JB. Larsen MT, et al. Among authors: glenthoj a. Blood. 2014 Feb 13;123(7):1079-89. doi: 10.1182/blood-2013-08-523233. Epub 2014 Jan 7. Blood. 2014. PMID: 24398327 Free article.

6

Olfactomedin 4 defines a subset of human neutrophils.

Clemmensen SN, Bohr CT, Rørvig S, Glenthøj A, Mora-Jensen H, Cramer EP, Jacobsen LC, Larsen MT, Cowland JB, Tanassi JT, Heegaard NH, Wren JD, Silahtaroglu AN, Borregaard N. Clemmensen SN, et al. Among authors: glenthoj a. J Leukoc Biol. 2012 Mar;91(3):495-500. doi: 10.1189/jlb.0811417. Epub 2011 Dec 20. J Leukoc Biol. 2012. PMID: 22187488 Free PMC article.

7

Human α-defensin expression is not dependent on CCAAT/enhancer binding protein-ε in a murine model.

Glenthøj A, Dahl S, Larsen MT, Cowland JB, Borregaard N. Glenthøj A, et al. PLoS One. 2014 Mar 21;9(3):e92471. doi: 10.1371/journal.pone.0092471. eCollection 2014. PLoS One. 2014. PMID: 24658030 Free PMC article.

8

No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer.

Cramer EP, Glenthøj A, Häger M, Juncker-Jensen A, Engelholm LH, Santoni-Rugiu E, Lund LR, Laerum OD, Cowland JB, Borregaard N. Cramer EP, et al. Among authors: glenthoj a. PLoS One. 2012;7(6):e39646. doi: 10.1371/journal.pone.0039646. Epub 2012 Jun 21. PLoS One. 2012. PMID: 22737251 Free PMC article.

9

ProHNPs are the principal α-defensins of human plasma.

Glenthøj A, Glenthøj AJ, Borregaard N. Glenthøj A, et al. Among authors: glenthoj aj. Eur J Clin Invest. 2013 Aug;43(8):836-43. doi: 10.1111/eci.12114. Epub 2013 May 30. Eur J Clin Invest. 2013. PMID: 23718714

10

Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo.

Glenthøj A, Nickles K, Cowland J, Borregaard N. Glenthøj A, et al. PLoS One. 2015 May 6;10(5):e0125483. doi: 10.1371/journal.pone.0125483. eCollection 2015. PLoS One. 2015. PMID: 25945506 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page